Rational design and characterisation of intranasal gel incorporating eletriptan HBr-loaded solid lipid nanoparticles for enhanced brain delivery in migraine.

Researchers developed a new nasal gel to deliver eletriptan HBr for migraines. This gel uses solid lipid nanoparticles to improve how the drug reaches the brain. Traditional methods often struggle with the body's metabolism and barriers. The scientists used special polymers and lipids to enhance delivery. They optimized the gel's formulation through careful testing. The resulting nanoparticles are about 257.4 nm in size and have a good stability profile. The gel forms quickly at body temperature and has a suitable viscosity for nasal application. In tests, the new gel allowed more of the drug to permeate compared to a standard formulation. This means it could potentially provide faster relief for migraine sufferers. Overall, this research shows promise for improving migraine treatment through innovative drug delivery methods. Clinical relevance: This research indicates that a new nasal gel could significantly enhance migraine treatment effectiveness.